Anti-programmed death-1 inhibitor nivolumab-induced immune-related adverse events: hepatitis, renal insufficiency, myositis, vitiligo, and hypothyroidism: a case-based review.

Zekic, Tatjana; Benic, Mirjana Stanic

Zekic, Tatjana; Benic, Mirjana Stanic.

Affiliation

Zekic T; Faculty of Medicine, Clinical Hospital Center Rijeka, Department of Rheumatology and Clinical Immunology, University of Rijeka, Rijeka, Croatia. tatjana.zekic@ri.t-com.hr.
Benic MS; Department of Pharmacology, Clinical Hospital Center Rijeka, Rijeka, Croatia.

Rheumatol Int ; 43(3): 559-565, 2023 Mar.

Article in En | MEDLINE | ID: mdl-36449057

Subject(s)

Carcinoma, Renal Cell; Drug-Related Side Effects and Adverse Reactions; Hepatitis; Hypothyroidism; Kidney Neoplasms; Myositis; Renal Insufficiency; Vitiligo; Male; Humans; Aged; Nivolumab/adverse effects; Carcinoma, Renal Cell/chemically induced; Carcinoma, Renal Cell/drug therapy; Carcinoma, Renal Cell/pathology; Vitiligo/chemically induced; Vitiligo/drug therapy; Creatinine; Kidney Neoplasms/chemically induced; Kidney Neoplasms/drug therapy; Kidney Neoplasms/pathology; Myositis/drug therapy; Dexamethasone/adverse effects

Key words

Chronic; Hepatitis; Myositis; PD-L1 Inhibitors; Renal Insufficiency; Thyroid gland; Toxic; Vitiligo

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vitiligo / Carcinoma, Renal Cell / Drug-Related Side Effects and Adverse Reactions / Renal Insufficiency / Hepatitis / Hypothyroidism / Kidney Neoplasms / Myositis Limits: Aged / Humans / Male Language: En Journal: Rheumatol Int Year: 2023 Type: Article Affiliation country: Croatia

Fulltext

XML

PubMed Links

Search on Google